# Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)

> **NCT00250068** · PHASE2 · COMPLETED · sponsor: **University of New Mexico** · enrollment: 8 (actual)

## Conditions studied

- Lung Diseases
- Cancer

## Interventions

- **DRUG:** Liposomal 9-Nitrocamptothecin

## Key facts

- **NCT ID:** NCT00250068
- **Lead sponsor:** University of New Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2010-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00250068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00250068, "Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00250068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*